Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Molecular Medicine Congress

Mike Makrigiorgos's Biography



Mike Makrigiorgos, Professor, Dana-Farber Cancer Institute/Harvard Medical School

Dr. Makrigiorgos is Professor and Director of the Medical Physics and Biophysics Division of the combined Radiation Oncology Department at Dana Farber Cancer Institute, Brigham and Women’s and Children’s Hospitals, at Harvard Medical School, Boston, USA. He is also Director of the DNA technology laboratory and the radiation pre-clinical facility. He is a Member of the Editorial Board of Clinical Chemistry and has published over 100 articles, reviews and book chapters. His research interests include the development of novel DNA technologies for molecular diagnostics with application in Oncology. He is the inventor of several novel PCR-based techniques for molecular diagnostics, including Balanced-PCR, Anti-primer-quenching-real-time PCR, Hairpin-PCR and COLD-PCR.

Mike Makrigiorgos Image

Enrichment of Genomic Fractions for Mutations Prior to Sequencing using COLD-PCR

Tuesday, 3 September 2013 at 14:15

Add to Calendar ▼2013-09-03 17:35:002013-09-03 18:35:00Europe/LondonEnrichment of Genomic Fractions for Mutations Prior to Sequencing using COLD-PCRMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com

Rare mutations in clinical samples can have major prognostic and predictive implications, yet they are difficult to detect using sequencing.  We present novel enhancements in COLD-PCR technology that enable enrichment of mutations in large genomic fractions prior to high throughput sequencing, thus enabling their detection.

Enrichment of Genomic Fractions for Mutations Prior to Sequencing using COLD-PCR

Tuesday, 3 September 2013 at 14:15

Add to Calendar ▼2013-09-03 17:35:002013-09-03 18:35:00Europe/LondonEnrichment of Genomic Fractions for Mutations Prior to Sequencing using COLD-PCRMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com

Rare mutations in clinical samples can have major prognostic and predictive implications, yet they are difficult to detect using sequencing.  We present novel enhancements in COLD-PCR technology that enable enrichment of mutations in large genomic fractions prior to high throughput sequencing, thus enabling their detection.

Enrichment of Genomic Fractions for Mutations Prior to Sequencing using COLD-PCR

Tuesday, 3 September 2013 at 17:35

Add to Calendar ▼2013-09-03 17:35:002013-09-03 18:35:00Europe/LondonEnrichment of Genomic Fractions for Mutations Prior to Sequencing using COLD-PCRMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com

Rare mutations in clinical samples can have major prognostic and predictive implications, yet they are difficult to detect using sequencing.  We present novel enhancements in COLD-PCR technology that enable enrichment of mutations in large genomic fractions prior to high throughput sequencing, thus enabling their detection.


Add to Calendar ▼2013-09-03 00:00:002013-09-04 00:00:00Europe/LondonMolecular Medicine CongressMolecular Medicine Congress in Frankfurt, GermanyFrankfurt, GermanySELECTBIOenquiries@selectbiosciences.com